Pharvaris N.V.

NASDAQ (USD): Pharvaris N.V. (PHVS)

Last Price

20.55

Today's Change

+0.51 (2.54%)

Day's Change

20.01 - 20.55

Trading Volume

14,947

Overview

Market Cap

1 Billion

Shares Outstanding

54 Million

Avg Volume

104,745

Avg Price (50 Days)

20.71

Avg Price (200 Days)

20.99

PE Ratio

-7.42

EPS

-2.77

Earnings Announcement

24-Apr-2025

Previous Close

20.04

Open

20.01

Day's Range

20.01 - 20.55

Year Range

15.0 - 33.0

Trading Volume

14,947

Price Change Highlight

1 Day Change

2.54%

5 Day Change

-8.34%

1 Month Change

-1.30%

3 Month Change

7.09%

6 Month Change

-7.01%

Ytd Change

-20.56%

1 Year Change

25.30%

3 Year Change

29.25%

5 Year Change

-29.14%

10 Year Change

-29.14%

Max Change

-29.14%

News and Blogs
Latest Hottest Following

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Biotechnology

Description:

Pharvaris N.V., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for rare diseases. The company develops PHA121, a small molecule bradykinin B2-receptor antagonist that is in Phase II clinical trial for the treatment of hereditary angioedema (HAE). It also develops PHVS416, an on-demand, rapid exposure soft capsule for patients suffering from acute HAE attacks and is under Phase 2 clinical trial; and PHVS719, a prophylactic extended-release tablet for HAE patients and is under Phase 1 clinical trial. It operates in the Netherlands, Switzerland, and the United States. The company was incorporated in 2015 and is based in Leiden, the Netherlands.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment